Atıf İçin Kopyala
Arat M., Idilman R., Soydan E., Soykan I., Erden E., Karayalcin S., ...Daha Fazla
CLINICAL TRANSPLANTATION, cilt.19, sa.6, ss.798-803, 2005 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
19
Sayı:
6
-
Basım Tarihi:
2005
-
Doi Numarası:
10.1111/j.1399-0012.2005.00424.x
-
Dergi Adı:
CLINICAL TRANSPLANTATION
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.798-803
-
Anahtar Kelimeler:
allogeneic hematopoietic cell transplantation, cholestatic liver diseases, chronic graft-vs.-host disease, ursodeoxycholic acid, PRIMARY BILIARY-CIRRHOSIS, STEM-CELL TRANSPLANTATION, HEPATOBILIARY DISORDERS, BONE-MARROW, MECHANISMS, THERAPY
-
Ankara Üniversitesi Adresli:
Evet
Özet
Objectives: Data regarding the long-term treatment of ursodeoxycholic acid (UDCA) in individuals of chronic graft-vs.-host disease (cGVHD) of the liver are limited. The aims of this prospective study were to determine whether, (i) UDCA treatment is useful as a long-term treatment for individuals with limited cGVHD of the liver following allogeneic hematopoietic cell transplantation, and (ii) the tolerability of UDCA treatment in such individuals.